Condition: Head and Neck Cancer · Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
The goal of this study is to evaluate the safety and efficacy of the stereotactic boost applied in patients with H\&N tumours.
This description comes directly from the study's public registry record.
Paweł Polanowski, PhD · 48322788313 · pawel.polanowski@gliwice.nio.gov.pl
Krzysztof Skladowski · 48322788329 · krzysztof.skladowski@gliwice.nio.gov.pl
Always discuss trial participation with your own doctor first.
| 1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, | Gliwice, Gliwicw, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06472570